Cytiva

Pall Corporation is a global leader in the high-tech filtration, separation, and purification industry, generating approximately $2.7 billion in revenue with a workforce of nearly 11,000 employees worldwide. The company serves a diverse range of sectors, including life sciences, industrial applications, and food and beverage manufacturing. Pall Life Sciences offers advanced products and services that support the development and production of biotech drugs, vaccines, cell therapies, and pharmaceuticals, often acting as a critical safeguard against pathogens. In the industrial sector, Pall provides filtration solutions for various industries, including microelectronics, aerospace, petrochemicals, and power generation, ensuring equipment reliability and efficiency. Additionally, Pall’s engineered solutions assist municipal and industrial customers in addressing water quality and scarcity challenges, while also supporting energy companies in maximizing production and developing innovative fuels. Headquartered in Port Washington, New York, Pall has a global presence with offices and manufacturing facilities worldwide.

CEVEC Pharmaceuticals GmbH is a biopharmaceutical company based in Cologne, Germany, specializing in the production of therapeutic proteins and monoclonal antibodies using a unique human cell-based expression system. Founded in 2001, CEVEC has developed the CAP-GO platform, which allows for the efficient production of complex, glycosylated proteins that are challenging to express using conventional cell lines. This platform includes optimized expression vectors, serum- and animal component-free cell line generation, and stable pool generation for recombinant proteins. Additionally, CEVEC offers the CAP-GT platform, facilitating large-scale production of gene therapy vectors, including Lentiviral, Adenoviral, and AAV types. The company also provides contract manufacturing services and has established a strategic collaboration with BioLamina AB, enhancing its capabilities in the biopharmaceutical sector.

Intermountain Life Sciences, founded in 2014, operates a state-of-the-art cGMP facility dedicated to the manufacturing of essential products for the pharmaceutical and biopharmaceutical industries. The company specializes in producing Water for Pharmaceutical Purposes, including distilled water for injection and cell and molecular sterile water, as well as phosphate-buffered saline and sodium chloride injection. Additionally, Intermountain Life Sciences offers custom bioprocess solutions tailored to meet the diverse needs of scientific research, medical device development, and therapeutic manufacturing workflows. Through its rigorous quality standards and advanced production capabilities, the company supports a wide range of applications within the life sciences sector.

GoSilico is a bioprocessing software developer based in Karlsruhe, Germany, specializing in solutions for the biopharmaceutical industry. The company focuses on digitalizing downstream process development through advanced computer simulation techniques. By providing software that enhances the modeling of biopharmaceutical processes, GoSilico enables companies to streamline their development workflows. In addition to its software offerings, the company also provides consulting and training services, helping clients to effectively implement and optimize their silico process frameworks. Through these services, GoSilico aims to support biopharmaceutical companies in improving efficiency and innovation in their product development efforts.

Vanrx Pharmasystems manufactures aseptic filling machines that improve the production of sterile injectables. Its products are used to make injectable dosages for a wide range of medical products, including vaccines, oncologicals, and biologic therapeutics. The company was founded in 2007 and is based in Burnaby, British Columbia.